- Home
- EQ vs LESL Comparison
EQ vs LESL Comparison
Compare EQ & LESL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQ
- LESL
- Stock Information
- Founded
- EQ 2017
- LESL 1963
- Country
- EQ United States
- LESL United States
- Employees
- EQ N/A
- LESL N/A
- Industry
- EQ Biotechnology: Pharmaceutical Preparations
- LESL Diversified Commercial Services
- Sector
- EQ Health Care
- LESL Miscellaneous
- Exchange
- EQ Nasdaq
- LESL Nasdaq
- Market Cap
- EQ 67.9M
- LESL 66.9M
- IPO Year
- EQ 2018
- LESL 2020
- Fundamental
- Price
- EQ $1.50
- LESL $0.28
- Analyst Decision
- EQ Hold
- LESL Hold
- Analyst Count
- EQ 2
- LESL 9
- Target Price
- EQ $1.00
- LESL $1.66
- AVG Volume (30 Days)
- EQ 2.5M
- LESL 1.9M
- Earning Date
- EQ 11-12-2025
- LESL 08-06-2025
- Dividend Yield
- EQ N/A
- LESL N/A
- EPS Growth
- EQ N/A
- LESL N/A
- EPS
- EQ N/A
- LESL N/A
- Revenue
- EQ $16,553,000.00
- LESL $1,250,568,000.00
- Revenue This Year
- EQ N/A
- LESL N/A
- Revenue Next Year
- EQ N/A
- LESL $0.64
- P/E Ratio
- EQ N/A
- LESL N/A
- Revenue Growth
- EQ N/A
- LESL N/A
- 52 Week Low
- EQ $0.27
- LESL $0.27
- 52 Week High
- EQ $2.35
- LESL $3.63
- Technical
- Relative Strength Index (RSI)
- EQ 48.79
- LESL 34.94
- Support Level
- EQ $1.78
- LESL $0.27
- Resistance Level
- EQ $2.02
- LESL $0.34
- Average True Range (ATR)
- EQ 0.26
- LESL 0.02
- MACD
- EQ -0.09
- LESL -0.00
- Stochastic Oscillator
- EQ 1.73
- LESL 12.60
About EQ Equillium Inc.
Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.
About LESL Leslie's Inc.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.